Get access to our best features
Get access to our best features
Published

Moderna wins Covid jab patent dispute over Pfizer and BioNTechFinancial Times

Summary by Financial Times
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources are Center
60% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)